Apomorphine

Chemical formula: C₁₇H₁₇NO₂  Molecular mass: 267.322 g/mol  PubChem compound: 6005

Therapeutic indications

Apomorphine is indicated for:

Treatment of motor fluctuations ("on-off" phenomena) in patients with Parkinson's disease

Population group: only adults (18 years old or older)

Apomorphine is indicated for the treatment of motor fluctuations (‘on-off’ phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral anti-Parkinson medication.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Apomorphine is contraindicated in the following cases:

Respiratory depression, dementia, psychotic diseases, hepatic insufficiency

at least one of
Decreased respiratory function
Respiratory insufficiency
Dementia
Psychotic disorder
Hepatic insufficiency

Levodopa, severe dyskinesia or dystonia

at least one of
Diurnal dystonia
Levodopa

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: KYNMOBI Sublingual film
Summary of Product Characteristics (SPC) 2022: APO-GO Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈